SEC Form 4Coverage since May 26, 2026
$GALT insider trading
Over the last 12 months, Galectin Therapeutics insiders reported no purchases and 5 sales totaling $522K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $522K 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $GALT · 12Mvia TradingView
Top insiders · 12m
Jamil KhurramChief Medical Officer4× · $371K
Shlevin Harold H.—1× · $151K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Jamil KhurramChief Medical Officer · O | ▼ Sale | 16,250 | $5.13 | $83K | -100% | plan |
| Jun 29, 2026 | Shlevin Harold H.D | ▼ Sale | 30,000 | $5.03 | $151K | -82.2% | plan · 2 tranches |
| Jun 29, 2026 | Jamil KhurramChief Medical Officer · O | ▼ Sale | 52,037 | $5.04 | $262K | -100% | plan · 3 tranches |
| Jun 23, 2026 | Jamil KhurramChief Medical Officer · O | ▼ Sale | 7,557 | $3.14 | $24K | -100% | plan |
| May 26, 2026 | Jamil KhurramChief Medical Officer · O | ▼ Sale | 568 | $3.1 | $2K | -100% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $GALT feed.